Careers
Media
Investors
Contact us
Company
Company
Purpose
Strategy
Leadership
History
Locations
Offering
Offering
Drug Substances
Exclusive synthesis
API portfolio
Drug Products
Oral solid dosage forms
Steriles
Ophthalmics
Inhalation products
Viral vectors
Technologies
Sustainability
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights
Company
Purpose
Strategy
Leadership
History
Locations
Offering
Drug Substances
Exclusive synthesis
API portfolio
Drug Products
Oral solid dosage forms
Steriles
Ophthalmics
Inhalation products
Viral vectors
Technologies
Sustainability
People
Environment
Integrity
Quality
Community engagement
Risk management
Insights
Careers
Media
Investors
Contact us
What are you
looking for?
Search
Home
/
News archive
/
Siegfried and BioNTech Sign Contract for the Aseptic Fill & Finish of a COVID-19 Vaccine
Back to overview
Media Release
Sep 14, 2020
Siegfried and BioNTech Sign Contract for the Aseptic Fill & Finish of a COVID-19 Vaccine
Download media release
Media release
Medienmitteilung (DE)
To top
